Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
European Journal of Cancer (Oxford, England : 1990)|July 15, 2016
A five-gene expression signature to predict progression in T1G3 bladder cancerAntoine G van der Heijden, Lourdes Mengual, Juan J Lozano, et al.
British Journal of Cancer|October 3, 2022
Multicentric validation of diagnostic tests based on BC-116 and BC-106 urine peptide biomarkers for bladder cancer in two prospective cohorts of patientsLourdes Mengual, Maria Frantzi, Marika Mokou, et al.
EJNMMI Research|December 18, 2024
cfDNA fragmentation patterns correlate with tumor burden measured via PSMA PET/CT volumetric parameters in patients with biochemical recurrence of prostate cancerGary Amseian, Marcel Figueras, Joel Mases, et al.
Oncotarget|September 9, 2017
Prognostic microRNAs in upper tract urothelial carcinoma: multicenter and international validation studyLaura Izquierdo, Ruth Montalbo, Mercedes Ingelmo-Torres, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|February 17, 2019
Ability of a urine gene expression classifier to reduce the number of follow-up cystoscopies in bladder cancer patientsRuth Montalbo, Juan J Lozano, Laura Izquierdo, et al.
Journal of Neuroscience Research|March 21, 2014
Identification of blood serum micro-RNAs associated with idiopathic and LRRK2 Parkinson's diseaseTeresa Botta-Orfila, Xavier Morató, Yaroslau Compta, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
An Association Study of Germline Variants in Bladder Cancer-Related Genes with the Prognosis of Non-Muscle Invasive Bladder CancerJasper P Hof, Sita H Vermeulen, Antoine G van der Heijden, et al.
European Journal of Cancer (Oxford, England : 1990)|January 14, 2016
Gene expression test for the non-invasive diagnosis of bladder cancer: A prospective, blinded, international and multicenter validation studyMaria J Ribal, Lourdes Mengual, Juan J Lozano, et al.
The Journal of Urology|September 25, 2019
The Role of Fluorescence In Situ Hybridization for Predicting Recurrence after Adjuvant bacillus Calmette-Guérin in Patients with Intermediate and High Risk Nonmuscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis of Individual Patient DataEsmée I M L Liem, Jorg R Oddens, Robin W M Vernooij, et al.
Molecular Cancer Therapeutics|March 25, 2014
Epithelial-to-mesenchymal transition mediates docetaxel resistance and high risk of relapse in prostate cancerMercedes Marín-Aguilera, Jordi Codony-Servat, Òscar Reig, et al.
Pageof 8